Michael H. Neale

1.0k total citations
26 papers, 820 citations indexed

About

Michael H. Neale is a scholar working on Molecular Biology, Oncology and Ophthalmology. According to data from OpenAlex, Michael H. Neale has authored 26 papers receiving a total of 820 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Molecular Biology, 9 papers in Oncology and 6 papers in Ophthalmology. Recurrent topics in Michael H. Neale's work include Ocular Oncology and Treatments (6 papers), Prion Diseases and Protein Misfolding (5 papers) and Cancer-related Molecular Pathways (5 papers). Michael H. Neale is often cited by papers focused on Ocular Oncology and Treatments (6 papers), Prion Diseases and Protein Misfolding (5 papers) and Cancer-related Molecular Pathways (5 papers). Michael H. Neale collaborates with scholars based in United Kingdom, Italy and Germany. Michael H. Neale's co-authors include Ian A. Cree, Richard A. Knight, Gerry Melino, Nyree Myatt, John L. Hungerford, Rami I. Aqeilan, Paolo Salomoni, Mario Rossi, Carlo M. Croce and Eleonora Candi and has published in prestigious journals such as Proceedings of the National Academy of Sciences, PLoS ONE and Molecular and Cellular Biology.

In The Last Decade

Michael H. Neale

26 papers receiving 806 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Michael H. Neale United Kingdom 15 514 371 146 98 76 26 820
Konstantin S. Spirin United States 12 651 1.3× 449 1.2× 77 0.5× 56 0.6× 102 1.3× 15 1.1k
Mallikarjuna Kandalam India 16 342 0.7× 236 0.6× 241 1.7× 119 1.2× 62 0.8× 27 592
Mirentxu Santos Spain 20 855 1.7× 529 1.4× 68 0.5× 84 0.9× 180 2.4× 43 1.3k
Brigitte L. Thériault Canada 12 519 1.0× 299 0.8× 140 1.0× 69 0.7× 120 1.6× 18 757
Hideo Maki Japan 10 476 0.9× 182 0.5× 30 0.2× 51 0.5× 71 0.9× 15 789
Joakim Karlsson Sweden 13 272 0.5× 278 0.7× 146 1.0× 176 1.8× 31 0.4× 24 572
Marie‐Jeanne Pillaire France 20 1.1k 2.2× 367 1.0× 35 0.2× 49 0.5× 107 1.4× 33 1.3k
Lauren G. Aoude Australia 16 634 1.2× 434 1.2× 202 1.4× 200 2.0× 137 1.8× 29 1.0k
R. M. Sharrard United Kingdom 17 457 0.9× 229 0.6× 51 0.3× 121 1.2× 71 0.9× 31 866
Ruth Halaban United States 10 381 0.7× 389 1.0× 22 0.2× 205 2.1× 230 3.0× 17 795

Countries citing papers authored by Michael H. Neale

Since Specialization
Citations

This map shows the geographic impact of Michael H. Neale's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael H. Neale with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael H. Neale more than expected).

Fields of papers citing papers by Michael H. Neale

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michael H. Neale. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael H. Neale. The network helps show where Michael H. Neale may publish in the future.

Co-authorship network of co-authors of Michael H. Neale

This figure shows the co-authorship network connecting the top 25 collaborators of Michael H. Neale. A scholar is included among the top collaborators of Michael H. Neale based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michael H. Neale. Michael H. Neale is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Tark, Dongseob, Hyojin Kim, Michael H. Neale, et al.. (2015). Generation of a Persistently Infected MDBK Cell Line with Natural Bovine Spongiform Encephalopathy (BSE). PLoS ONE. 10(2). e0115939–e0115939. 11 indexed citations
2.
Massie, Isobel, Marc Dziasko, Alvena Kureshi, et al.. (2014). Advanced Imaging and Tissue Engineering of the Human Limbal Epithelial Stem Cell Niche. Methods in molecular biology. 1235. 179–202. 17 indexed citations
3.
Neale, Michael H., et al.. (2014). Culture and Characterization of Oral Mucosal Epithelial Cells on a Fibrin Gel for Ocular Surface Reconstruction. Current Eye Research. 40(11). 1077–1087. 23 indexed citations
4.
Purchase, Diane, Hemda Garelick, Roger J. Morris, et al.. (2013). Enzymatic Formulation Capable of Degrading Scrapie Prion under Mild Digestion Conditions. PLoS ONE. 8(7). e68099–e68099. 24 indexed citations
5.
Chaplin, Melanie J., M.J. Stack, Michael H. Neale, et al.. (2011). Detection and Localisation of PrPSc in the Liver of Sheep Infected with Scrapie and Bovine Spongiform Encephalopathy. PLoS ONE. 6(5). e19737–e19737. 12 indexed citations
6.
Edwards, Jane C., et al.. (2010). PrPSc is associated with B cells in the blood of scrapie-infected sheep. Virology. 405(1). 110–119. 16 indexed citations
7.
Vernole, Patrizia, Michael H. Neale, Daniela Barcaroli, et al.. (2009). TAp73α binds the kinetochore proteins Bub1 and Bub3 resulting in polyploidy. Cell Cycle. 8(3). 421–429. 26 indexed citations
8.
Barcaroli, Daniela, David Dinsdale, Michael H. Neale, et al.. (2006). FLASH is an essential component of Cajal bodies. Proceedings of the National Academy of Sciences. 103(40). 14802–14807. 50 indexed citations
9.
Munarriz, Eliana, Daniela Barcaroli, Anastasis Stephanou, et al.. (2004). PIAS-1 Is a Checkpoint Regulator Which Affects Exit from G1 and G2 by Sumoylation of p73. Molecular and Cellular Biology. 24(24). 10593–10610. 72 indexed citations
10.
Sharma, Sanjay, Michael H. Neale, Federica Di Nicolantonio, et al.. (2003). Outcome of ATP-based tumor chemosensitivity assay directed chemotherapy in heavily pre-treated recurrent ovarian carcinoma. BMC Cancer. 3(1). 19–19. 56 indexed citations
11.
Nicolantonio, Federica Di, et al.. (2003). The Chemosensitivity Profile of Retinoblastoma. Recent results in cancer research. 161. 73–80. 9 indexed citations
12.
Neale, Michael H., Nyree Myatt, P C Weaver, et al.. (2001). Comparison of the ex vivo chemosensitivity of uveal and cutaneous melanoma. Melanoma Research. 11(6). 601–609. 35 indexed citations
13.
Neale, Michael H., Peter Charlton, & Ian A. Cree. (2000). Ex vivo activity of XR5000 against solid tumors. Anti-Cancer Drugs. 11(6). 471–478. 7 indexed citations
14.
Neale, Michael H., Robert Alexander, Nyree Myatt, et al.. (2000). Relationship between expression of topoisomerase II isoforms and chemosensitivity in choroidal melanoma. The Journal of Pathology. 192(2). 174–181. 14 indexed citations
15.
Myatt, Nyree, Petros Aristodemou, Michael H. Neale, et al.. (2000). Abnormalities of the transforming growth factor-beta pathway in ocular melanoma. The Journal of Pathology. 192(4). 511–518. 20 indexed citations
16.
Myatt, Nyree, Petros Aristodemou, Michael H. Neale, et al.. (2000). Abnormalities of the transforming growth factor‐beta pathway in ocular melanoma. The Journal of Pathology. 192(4). 511–518. 1 indexed citations
17.
Neale, Michael H., Alan Lamont, Andrew Hindley, Christian M. Kurbacher, & Ian A. Cree. (2000). The ex vivo effect of high concentrations of doxorubicin on recurrent ovarian carcinoma. Anti-Cancer Drugs. 11(10). 865–871. 14 indexed citations
18.
Neale, Michael H., Nyree Myatt, Ian A. Cree, et al.. (1999). Combination chemotherapy for choroidal melanoma: ex vivo sensitivity to treosulfan with gemcitabine or Cytosine arabinoside. British Journal of Cancer. 79(9-10). 1487–1493. 55 indexed citations
19.
Chana, J., George D. Wilson, Ian A. Cree, et al.. (1999). c-myc, p53, and Bcl-2 expression and clinical outcome in uveal melanoma. British Journal of Ophthalmology. 83(1). 110–114. 78 indexed citations
20.
Cree, Ian A., Michael H. Neale, Nyree Myatt, et al.. (1999). Heterogeneity of chemosensitivity of metastatic cutaneous melanoma. Anti-Cancer Drugs. 10(5). 437–444. 45 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026